XML 82 R41.htm IDEA: XBRL DOCUMENT v3.2.0.727
BUSINESS COMBINATIONS - Estimated fair values of the assets acquired and liabilities assumed (Details) - USD ($)
$ in Millions
Jun. 30, 2015
Apr. 01, 2015
Dec. 31, 2014
Jul. 07, 2014
Jan. 23, 2014
Assets acquired and liabilities assumed          
Goodwill $ 17,233.1   $ 9,346.4    
Salix          
Assets acquired and liabilities assumed          
Cash and cash equivalents   $ 113.7      
Inventories   233.2      
Other current assets   1,400.3      
Property, plant and equipment, net   24.3      
Identifiable intangible assets, excluding acquired IPR&D   6,756.3      
Acquired IPR&D   5,366.8      
Current liabilities   (1,764.2)      
Contingent consideration, short term portion   (327.9)      
Long-term debt, including current portion   (3,123.1)      
Deferred income taxes, net   (3,512.0)      
Other non-current liabilities   (7.3)      
Total identifiable net assets   5,160.1      
Goodwill   7,971.9      
Total fair value of consideration transferred   $ 13,132.0      
Other 2015 Acquisitions          
Assets acquired and liabilities assumed          
Cash and cash equivalents 81.1        
Accounts receivable 25.4        
Inventories 107.0        
Other current assets 18.1        
Property, plant and equipment, net 57.8        
Identifiable intangible assets, excluding acquired IPR&D 882.1        
Acquired IPR&D 24.0        
Other non-current assets 1.2        
Deferred tax asset, net 9.0        
Current liabilities (92.8)        
Non-current liabilities (96.0)        
Total identifiable net assets 1,016.9        
Goodwill 55.0        
Total fair value of consideration transferred 1,071.9        
Other 2015 Acquisitions | Amounts Recognized as of Acquisition Date (as previously reported)          
Assets acquired and liabilities assumed          
Cash and cash equivalents     81.1    
Accounts receivable     25.4    
Inventories     107.3    
Other current assets     18.1    
Property, plant and equipment, net     72.1    
Identifiable intangible assets, excluding acquired IPR&D     874.7    
Acquired IPR&D     25.5    
Other non-current assets     1.2    
Deferred tax asset, net     5.8    
Current liabilities     (92.8)    
Non-current liabilities     (96.0)    
Total identifiable net assets     1,022.4    
Goodwill     55.9    
Total fair value of consideration transferred     1,078.3    
Other 2015 Acquisitions | Measurement Period Adjustments          
Assets acquired and liabilities assumed          
Cash and cash equivalents     0.0    
Accounts receivable     0.0    
Inventories     (0.3)    
Other current assets     0.0    
Property, plant and equipment, net     (14.3)    
Identifiable intangible assets, excluding acquired IPR&D     7.4    
Acquired IPR&D     (1.5)    
Other non-current assets     0.0    
Deferred tax asset, net     3.2    
Current liabilities     0.0    
Non-current liabilities     0.0    
Total identifiable net assets     (5.5)    
Goodwill     (0.9)    
Total fair value of consideration transferred     (6.4)    
2014 Acquisitions          
Assets acquired and liabilities assumed          
Cash and cash equivalents 34.7        
Accounts receivable 81.8        
Assets held for sale 124.9        
Inventories 154.6        
Other current assets 14.3        
Property, plant and equipment, net 61.2        
Identifiable intangible assets, excluding acquired IPR&D 711.8        
Acquired IPR&D 63.0        
Other non-current assets 1.9        
Current liabilities (173.8)        
Long-term debt, including current portion (11.2)        
Deferred income taxes, net (75.5)        
Other non-current liabilities (13.5)        
Total identifiable net assets 974.2        
Noncontrolling interest (14.7)        
Goodwill 456.5        
Total fair value of consideration transferred less noncontrolling interest     1,420.0    
Gross contractual amount of trade accounts receivable acquired 88.0        
Expected uncollectible of trade accounts receivable acquired 6.0        
2014 Acquisitions | Amounts Recognized as of Acquisition Date (as previously reported)          
Assets acquired and liabilities assumed          
Cash and cash equivalents     33.6    
Accounts receivable     87.7    
Assets held for sale     125.7    
Inventories     170.4    
Other current assets     19.1    
Property, plant and equipment, net     58.5    
Identifiable intangible assets, excluding acquired IPR&D     697.2    
Acquired IPR&D     65.8    
Other non-current assets     4.0    
Current liabilities     (152.0)    
Long-term debt, including current portion     (11.2)    
Deferred income taxes, net     (116.0)    
Other non-current liabilities     (13.4)    
Total identifiable net assets     969.4    
Noncontrolling interest     (15.0)    
Goodwill     410.4    
Total fair value of consideration transferred less noncontrolling interest     1,364.8    
2014 Acquisitions | Measurement Period Adjustments          
Assets acquired and liabilities assumed          
Cash and cash equivalents     1.1    
Accounts receivable     (5.9)    
Assets held for sale     (0.8)    
Inventories     (15.8)    
Other current assets     (4.8)    
Property, plant and equipment, net     2.7    
Identifiable intangible assets, excluding acquired IPR&D     14.6    
Acquired IPR&D     (2.8)    
Other non-current assets     (2.1)    
Current liabilities     (21.8)    
Long-term debt, including current portion     0.0    
Deferred income taxes, net     40.5    
Other non-current liabilities     (0.1)    
Total identifiable net assets     4.8    
Noncontrolling interest     0.3    
Goodwill     46.1    
Total fair value of consideration transferred less noncontrolling interest     51.2    
PreCision Dermatology, Inc.          
Assets acquired and liabilities assumed          
Total fair value of consideration transferred       $ 459.0  
Solta Medical, Inc.          
Assets acquired and liabilities assumed          
Total fair value of consideration transferred         $ 293.0
Developed Markets          
Assets acquired and liabilities assumed          
Goodwill 15,062.9   7,115.0    
Developed Markets | PreCision Dermatology, Inc.          
Assets acquired and liabilities assumed          
Goodwill       194.0  
Developed Markets | Solta Medical, Inc.          
Assets acquired and liabilities assumed          
Goodwill       56.0  
Emerging Markets          
Assets acquired and liabilities assumed          
Goodwill $ 2,170.2   $ 2,231.4    
Emerging Markets | Solta Medical, Inc.          
Assets acquired and liabilities assumed          
Goodwill       $ 38.0